跳至主要内容
临床试验/NCT02797249
NCT02797249已完成3 期

Low Dose Aspirin in the Prevention of Preeclampsia in Chinese Pregnant Women.

Peking University First Hospital1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2016年12月7日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
1,000
试验地点
1
主要终点
Prevention of preeclampsia

研究概览

简要总结

Preeclampsia is one of the three leading causes of maternal morbidity and mortality all over the world. The use of low dose aspirin has been mentioned in several studies with promising results. The investigators decided to evaluate the use of low dose aspirin in Chinese pregnant women, starting between 12+ and 20 weeks of pregnancy, based on clinical characteristics aiming to reduce the incidence of preeclampsia.

详细描述

Detailed Description:

The investigators will conduct a randomized control trial to estimate the efficacy of low dose aspirin in preventing preeclampsia in Chinese pregnant women who are evaluated with risk factors. The investigators will also obtain biological specimen including maternal blood, cord blood, placenta specimen and etc. for basic science studies.

Rationale for Design:There is a lack of evidences or guideline of aspirin using in preventing PE for Chinese women. The investigators will conduct a randomized control trial, which is the 'gold standard' of research design, hoping to answer the question.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Gestational age between 12+ and 20 weeks of pregnancy
  • High risk of preeclampsia, based in clinical risk factors as:
  • 2.1 if they have one or more of the following risk factors: Preeclampsia in a previous pregnancy ,Diabetes Mellitus(Type 1 or 2),Chronic Hypertension .
  • 2.2 if they have two or more of the following risk factors: Pre-pregnancy Body Mass Index ≥28kg/m2, Elderly pregnancy(age ≥35 years), Mother or sisters with preeclampsia in a previous pregnancy, Primiparity or Famliy history (Mother or sister that developed preeclampsia in a previous pregnancy).
  • Signed informed consent.

排除标准

  • Allergy to aspirin
  • Peptic ulcers
  • Severe heart, liver, renal disease who can not burden the experiment
  • Rheumatic immune disease
  • Mental disease
  • Alcohol and drug abuse
  • Being in another drug experiment within 3 months
  • Difficult to follow-up

研究组 & 干预措施

aspirin

Experimental

Low dose aspirin (100 mg) starting between 12+ and 20 weeks of pregnancy until 34 weeks of pregnancy, taking at night.

干预措施: Aspirin (Drug)

blank

Other

Routine examination during pregnancy.

干预措施: Blank (Other)

结局指标

主要结局

Prevention of preeclampsia

时间窗: 6 months

The number of cases of preeclampsia that appear in both groups before 34 weeks of pregnancy.

次要结局

  • Maternal hemorrhage and neonatal intracranial hemorrhage(6 months)
  • Preterm birth(6 months)
  • Prevention of preeclampsia at term(6 months)
  • Fetal Growth Restriction(6 months)
  • Abruptio placenta(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Li Lin

PhD

Peking University First Hospital

研究点 (1)

Loading locations...

相似试验

Low Dose Aspirin in the Prevention of Preeclampsia... | 临床试验